Audio is streamed directly from the publisher (api.riverside.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
2025 is set to change the industry. The new administration is poised to challenge many existing processes. The question is whether they will be based on data-driven analysis or ideologies and beliefs.
Our guests address this concern along with the existing challenges CEOs face, particularly manufacturing processes.
Additionally, they discuss weight loss drugs, focusing on GLP-1s, with medical precision.
Host
Lori Ellis, Head of Insights, BioSpace
Guests
Miguel Forte, President, International Society for Cell & Gene Therapy; Board Member, ARM; CEO and Board Member, Kiji Therapeutics
Ali Pashazadeh, Founder, Treehill Partners